Jeff Davis: Fan of Miracle Comebacks
Jeff Davis - West Coast Florida Back in 1969 the New York Mets, a struggling team at the time, pulled off one of the most amazing comebacks in baseball. You could say [...]
Jeff Davis - West Coast Florida Back in 1969 the New York Mets, a struggling team at the time, pulled off one of the most amazing comebacks in baseball. You could say [...]
As the Life Raft Group continues to grow globally, we will highlight our international friends in each newsletter issue. In this interview with Ferdinand Mwangura, Chairman of Henzo Kenya, we discover how the seeds [...]
Cancer patients are surviving longer thanks to breakthrough treatments like targeted therapies. With the additional longevity, however, is the responsibility to consider other health issues that may manifest, either due to treatments such as [...]
Novartis Pharmaceuticals recently received FDA approval for panobinostat, a blood cancer drug that targets multiple myeloma. This was a surprising ruling, as it was a turnaround from last year’s Oncologic Drugs Advisory Committee’s 5-2 [...]
A recent article in Forbes reports that although we are witnessing a time of historic breakthroughs in cancer treatments, we are lagging behind on policy breakthroughs in the development, funding and delivery of excellent cancer [...]
In spite of some medical professionals' claims to the contrary, cancer patients rarely request unnecessary tests or treatments according to a study cited in the JAMA journal Oncology. The study was completed at three [...]
The Life Raft Group joins the global community in honoring World Cancer Day 2015.We join with everyone in the cancer community: researchers, physicians, advocates, patient organizations, government agencies, and most importantly, patient and caregivers to [...]
Advocacy for GIST patients is a vital part of the work the Life Raft Group undertakes, but there are advocacy “superheroes” out there, going above and beyond to ensure that all GIST patients receive [...]
updated 1/20/21 Dr. mOe is an author, survivor, and dynamic mOe-tivational speaker. Diagnosed with GIST in 2012, Dr. mOe believes that God does not waste wounds. She is a freelance journalist, coach, mentor, [...]
With the onset of the patent expiration on Gleevec of the patent expiration on Gleevec for CML expiring in July and for GIST in June 2022 in the United States, it becomes more important than ever [...]